Related Experiment Video
Updated: Mar 17, 2026
08:27
Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model
Published on: April 16, 2014
16.5K
Orexin A attenuates palmitic acid-induced hypothalamic cell death.
Cayla M Duffy1, Joshua P Nixon1, Tammy A Butterick2
1Minneapolis Veterans Affairs Health Care System, Research 151, One Veterans Dr, Minneapolis, MN 55417, USA; Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Ave, St. Paul, MN 55108, USA.
Molecular and Cellular Neurosciences
|July 25, 2016
Summary
Orexin A (OXA) protects hypothalamic cells from palmitic acid (PA) damage by reducing oxidative stress and improving cellular metabolism. This suggests OXA may counteract harmful effects of obesogenic diets on brain health.
Area of Science:
- Neuroscience
- Metabolism
- Cell Biology
Background:
- Palmitic acid (PA), a dietary saturated fat, drives obesity and hypothalamic dysfunction via oxidative stress, insulin resistance, and neuroinflammation.
- PA exposure increases reactive oxygen species (ROS), leading to neuronal apoptosis and altered gene expression (e.g., decreased Bcl-2, increased Bax).
- Orexin A (OXA), a neuropeptide involved in obesity resistance, exhibits neuroprotective properties and can mitigate oxidative stress-induced cell death.
Purpose of the Study:
- To investigate the neuroprotective effects of Orexin A (OXA) against Palmitic Acid (PA)-induced cell death in hypothalamic cells.
- To determine if OXA can prevent PA-induced oxidative stress, apoptosis, and metabolic dysfunction in the hypothalamus.
Main Methods:
- An immortalized hypothalamic cell line (mHypoA-1/2) was treated with OXA and PA.
- Caspase-3/7 apoptosis, gene expression of Bax and Bcl-2, ROS production, and cellular respiration (basal, maximum, ATP production, reserve capacity) were measured.
Main Results:
- OXA attenuated PA-induced cell death, reducing caspase-3/7 activity.
- OXA stabilized Bcl-2 expression and reduced the Bax/Bcl-2 ratio, inhibiting apoptosis.
- OXA inhibited ROS production and reversed PA-induced mitochondrial dysfunction, restoring cellular respiration and ATP production.
Conclusions:
- Orexin A (OXA) demonstrates significant neuroprotective effects against Palmitic Acid (PA)-induced hypothalamic cell damage.
- OXA mitigates PA-induced apoptosis and oxidative stress by modulating gene expression and ROS levels.
- OXA treatment reverses PA-induced metabolic deficits in hypothalamic cells, highlighting its potential role in combating diet-induced brain health issues.
